MULTIPLE MYELOMA

Multiple myeloma is a blood cancer related to lymphoma and leukemia. There is no cure for multiple myeloma, but treatments are available that slow down its progression. In multiple myeloma, a certain kind of white blood cell called a plasma cell begins to multiply abnormally. Normally, plasma cells are responsible for producing antibodies that help fight infections. But in multiple myeloma, excessive plasma cells release unhealthy levels of protein (called immunoglobulin) into the bones and blood. The excessive protein accumulates throughout the body, causing organ damage. The plasma cells also cause problems inside bones, where they multiply and crowd out normal blood cells. Inside the bone marrow, multiple myeloma plasma cells release chemicals that prompt the body to dissolve areas of bone. This creates weak areas of bone, which are called lytic lesions. As multiple myeloma progresses, plasma cells begin to spill out of the bone marrow and deposit elsewhere in the body, causing further organ damage.

Causes of multiple myeloma

Multiple myeloma's cause is unknown. Certain risk factors slightly increase a person's chances of developing multiple myeloma. The risk factors are: Age over 65 years, being an African; having a family member affected by multiple myeloma.

What are the symptoms?

Early on, multiple myeloma may cause no symptoms. As multiple myeloma progresses, plasma cells accumulate in the bones, causing these symptoms: bone pain; weakness and fatigue; weight loss. Uncommonly, plasma cells may accumulate in purplish lumps visible underneath the skin.

How is it diagnosed?
Most often, testing for multiple myeloma begins after a doctor discovers abnormal blood tests in someone with or without symptoms of multiple myeloma. Some common lab-test clues to the presence of multiple myeloma are: High blood calcium (hypercalcemia); Anaemia (low red blood cell count); Elevated creatinine (impaired kidney function); High protein levels in blood,

combined with a low albumin level (a "globulin gap"). When a doctor suspects multiple myeloma, tests of the blood, urine, and bones can make the diagnosis. The most important lab tests of the blood and urine are: Serum protein electrophoresis (SPEP) and Urine protein electrophoresis (UPEP). These lab tests detect the protein produced by abnormal plasma cells in multiple myeloma. Ninety-seven percent of people with multiple myeloma have an abnormal result on SPEP, UPEP, or both tests. An abnormal SPEP and/or UPEP may lead doctors to recommend a bone marrow biopsy. Imaging tests also help doctors make a diagnosis of multiple myeloma and measure its spread. Plain X-ray films of the body's large bones (called a skeletal survey) can identify spots of bone weakened by multiple myeloma. In a few people, a more sensitive CT scan, MRI, or PET scan may be needed to find bone involvement from multiple myeloma.

Multiple myeloma treatment

In general, multiple myeloma treatment primarily helps people who already have signs of organ damage from multiple myeloma. These signs include anaemia, high blood calcium, impaired kidney function, or bone lytic lesions. The most effective treatment for multiple myeloma is stem cell transplantation (SCT): Multiple myeloma research is ongoing, including clinical trials to identify more effective chemotherapy drugs and combinations.